The present invention pertains to medical devices, and methods for manufacturing medical devices. More particularly, the present invention pertains to elongated intracorporal medical devices including a slotted tubular member.
A wide variety of intracorporal medical devices have been developed for medical use, for example, intravascular use. Some of these devices include guidewires, catheters, and the like. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices as well as alternative methods for manufacturing and using medical devices.
The invention provides design, material, manufacturing method, and use alternatives for medical devices. An example medical device may include a metallic tubular member including a tube wall defining an inner diameter and having a wall thickness. The tubular member may have a plurality of slots formed therein. The tubular member may also include first portion having a first length. The tube wall may have a substantially constant wall thickness across the first length. The tubular member may also include a second portion having a second length. The tube wall may thin so that the inner diameter increases across the second length.
An example guidewire may include a metallic tubular member having a tube wall, an outer diameter, and a distal end region. The distal end region may have a thinned length. The tube wall may thin so that the outer diameter decreases across the thinned length. The tubular member may have a plurality of slots formed therein. A tip member may be attached to the distal end region. The tip member may overlap with the thinned length.
Another example guidewire may include a metallic tubular member having a tube wall, an inner diameter, and a distal end region. The distal end region may have a thinned length. The tube wall may thin so that the inner diameter increases across the thinned length. The tubular member may have a plurality of slots formed therein. A tip member may be attached to the distal end region. The tip member may overlap with the thinned length.
Another example medical device may include a metallic tubular member including a distal end. The tubular member may include a tube wall having an inner surface and an outer surface. At the distal end of the tubular member, the inner surface and the outer surface may taper to thin the tube wall.
An example method for manufacturing a medical device may include providing a metallic tubular member including a tube wall defining an inner diameter, forming a plurality of slots in the tubular member, and thinning a portion of the tube wall. Along the portion of the tube wall that is thinned the inner diameter may be increased.
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
Although medical device 10 is depicted in several of the drawings as a guidewire, it is not intended to be limited to just being a guidewire. Indeed, medical device 10 may take the form of any suitable guiding, diagnosing, or treating device (including catheters, endoscopic instruments and/or endoscopes, laparoscopic instruments, stent delivery systems, embolic filter systems, urology stone retrieval systems, embolic coil delivery systems, atherectomy shafts, thermoctomy shafts, etc., and the like) and it may be suitable for use at essentially any location and/or body lumen within a patient. For example, medical device/guidewire 10 may be suitable for use in neurological interventions, coronary interventions, peripheral interventions, etc. As such, guidewire 10 may be appropriately sized for any given intervention. For example, guidewire 10 may have an outside diameter of about 0.001 to 0.5 inches or about 0.0015 to 0.05 inches (e.g., about 0.010 to 0.014 inches) for neurological interventions; an outside diameter of about 0.001 to 0.5 inches or about 0.01 to 0.05 inches (e.g., about 0.014 inches) for coronary interventions; or an outside diameter of about 0.01 to 0.5 inches or about 0.02 to 0.05 inches (e.g., about 0.014 to 0.038 inches) for peripheral interventions. These dimensions, of course, may vary depending on, for example, the type of device (e.g., catheter, guidewire, etc.), the anatomy of the patient, and/or the goal of the intervention. In at least some embodiments, for example, guidewire 10 may be a crossing guidewire that can be used to help a clinician cross an occlusion or stenosis in vessel 12.
In at least some embodiments, tubular member 20 includes a plurality of cuts, apertures, and/or slots 42 formed therein. Various embodiments of arrangements and configurations of slots 42 are contemplated. In some embodiments, at least some, if not all of slots 42 are disposed at the same or a similar angle with respect to the longitudinal axis of the tubular member 20. As shown, slots 42 can be disposed at an angle that is perpendicular, or substantially perpendicular, and/or can be characterized as being disposed in a plane that is normal to the longitudinal axis of tubular member 20. However, in other embodiments, slots 42 can be disposed at an angle that is not perpendicular, and/or can be characterized as being disposed in a plane that is not normal to the longitudinal axis of tubular member 20. Additionally, a group of one or more slots 42 may be disposed at different angles relative to another group of one or more slots 42. The distribution and/or configuration of slots 42 can also include, to the extent applicable, any of those disclosed in U.S. Pat. Publication No. US 2004/0181174, the entire disclosure of which is herein incorporated by reference.
Slots 42 may be provided to enhance the flexibility of tubular member 20 while still allowing for suitable torque transmission characteristics. Slots 42 may be formed such that one or more rings and/or turns interconnected by one or more segments and/or beams are formed in tubular member 20, and such rings and beams may include portions of tubular member 20 that remain after slots 42 are formed in the body of tubular member 20. Such an interconnected ring structure may act to maintain a relatively high degree of tortional stiffness, while maintaining a desired level of lateral flexibility. In some embodiments, some adjacent slots 42 can be formed such that they include portions that overlap with each other about the circumference of tubular member 20. In other embodiments, some adjacent slots 42 can be disposed such that they do not necessarily overlap with each other, but are disposed in a pattern that provides the desired degree of lateral flexibility.
Additionally, slots 42 can be arranged along the length of, or about the circumference of, tubular member 20 to achieve desired properties. For example, adjacent slots 42, or groups of slots 42, can be arranged in a symmetrical pattern, such as being disposed essentially equally on opposite sides about the circumference of tubular member 20, or can be rotated by an angle relative to each other about the axis of tubular member 20. Additionally, adjacent slots 42, or groups of slots 42, may be equally spaced along the length of tubular member 20, or can be arranged in an increasing or decreasing density pattern, or can be arranged in a non-symmetric or irregular pattern. Other characteristics, such as slot size, slot shape and/or slot angle with respect to the longitudinal axis of tubular member 20, can also be varied along the length of tubular member 20 in order to vary the flexibility or other properties. In other embodiments, moreover, it is contemplated that the portions of the tubular member, such as a proximal section 26, or a distal section 28, or the entire tubular member 20, may not include any such slots 42.
As suggested above, slots 42 may be formed in groups of two, three, four, five, or more slots 42, which may be located at substantially the same location along the axis of tubular member 20. Within the groups of slots 42, there may be included slots 42 that are equal in size (i.e., span the same circumferential distance around tubular member 20). In some of these as well as other embodiments, at least some slots 42 in a group are unequal in size (i.e., span a different circumferential distance around tubular member 20). Longitudinally adjacent groups of slots 42 may have the same or different configurations. For example, some embodiments of tubular member 20 include slots 42 that are equal in size in a first group and then unequally sized in an adjacent group. It can be appreciated that in groups that have two slots 42 that are equal in size, the beams (i.e., the portion of tubular member 20 remaining after slots 42 are formed therein) are aligned with the center of tubular member 20. Conversely, in groups that have two slots 42 that are unequal in size, the beams are offset from the center of tubular member 20. Some embodiments of tubular member 20 include only slots 42 that are aligned with the center of tubular member 20, only slots 42 that are offset from the center of tubular member 20, or slots 42 that are aligned with the center of tubular member 20 in a first group and offset from the center of tubular member 20 in another group. The amount of offset may vary depending on the depth (or length) of slots 42 and can include essentially any suitable distance.
Slots 42 can be formed by methods such as micro-machining, saw-cutting (e.g., using a diamond grit embedded semiconductor dicing blade), electron discharge machining, grinding, milling, casting, molding, chemically etching or treating, or other known methods, and the like. In some such embodiments, the structure of the tubular member 20 is formed by cutting and/or removing portions of the tube to form slots 42. Some example embodiments of appropriate micromachining methods and other cutting methods, and structures for tubular members including slots and medical devices including tubular members are disclosed in U.S. Pat. Publication Nos. 2003/0069522 and 2004/0181174-A2; and U.S. Pat. Nos. 6,766,720; and 6,579,246, the entire disclosures of which are herein incorporated by reference. Some example embodiments of etching processes are described in U.S. Pat. No. 5,106,455, the entire disclosure of which is herein incorporated by reference. It should be noted that the methods for manufacturing guidewire 10 may include forming slots 42 in tubular member 20 using any of these or other manufacturing steps.
In at least some embodiments, slots 42 may be formed in tubular member using a laser cutting process. The laser cutting process may include essentially any suitable laser and/or laser cutting apparatus. For example, the laser cutting process may utilize a fiber laser. Utilizing processes like laser cutting may be desirable for a number of reasons. For example, laser cutting processes may allow tubular member 20 to be cut into a number of different cutting patterns in a precisely controlled manner. This may include variations in the slot width (which also may be termed “kerf”), ring width, beam height and/or width, etc. Furthermore, changes to the cutting pattern can be made without the need to replace the cutting instrument (e.g., a blade). This may also allow smaller tubes (e.g., having a smaller outer diameter) to be used to form tubular member 20 without being limited by a minimum cutting blade size. Consequently, tubular members 20 may be fabricated for use in neurological devices or other devices where a small size may be desired.
As indicated above, slots 42 may be useful in that they may add desirable flexibility characteristics to tubular member 20. Tubular member 20 may also (or alternatively) include one or more additional structural features that desirably impact the flexibility characteristics. For example, tubular member 20 may include a tube wall 44 that defines an inner diameter ID and an outer diameter OD and, in at least some embodiments, tubular member 20 may include a region where tube wall 44 thins so that the inner diameter, the outer diameter, or both vary along the length of tubular member 20. Those portions of tubular member 20 that bear a thinned tube wall 44 may have increased flexibility. Because of this, these portions may be disposed at a desirable location in guidewire 10. For example, it may be desirable for the portions of tubular member 20 having a thinned tube wall 44 to be disposed adjacent joints or transitions, near the distal end or tip, adjacent other structures that may be more stiff or less flexible, or at any other suitable location along guidewire 10. Analogously, other structures of guidewire 10 may also be thinned in a similar way to provide desirable flexibility characteristics. Additionally, other medical devices and/or medical device components including, for example, coils, polymer sleeves, tips of balloons, the ends of stents, and the like may also be thinned to provide desirable flexibility characteristics.
Referring now to
Likewise,
Moreover,
For the above discussion, tube wall 44 thinning in a “linear” manner may be understood to mean that tube wall 44 thins at a substantially constant rate or along a substantially constant slope over a particular distance. Tube wall 44 thinning in a “curved” manner may be understood to mean that tube wall 44 thins at a constantly changing rate, or along a constantly changing slope (e.g., increasing, decreasing, or both), or along a shape that is curved over a particular distance. Tube wall 44 thinning in a “parabolic” manner may be understood to mean that tube wall 44 thins at a changing rate or along a changing slope (e.g., increasing, decreasing, or both), or along a shape that is parabolic over a particular distance. Tube wall 44 thinning in a “stepped” manner may be understood to mean that tube wall 44 thins along a series of one or more steps in wall thickness over a particular distance.
The above discussion indicates that tube wall 44 may be thinned in a linear manner, a curved manner, a parabolic manner, or a stepped manner. These specific manners of thinning tube wall 44 are not intended to limit the invention as tube wall 44 may be thinned in any suitable manner. Consequently, tube wall 44 may be thinned in a way that can be described by essentially any suitable mathematical equation, in any regular or irregular manner, randomly, or in any other suitable way.
In general, the thinning of tube wall 44 may increase the flexibility of tubular member 20 by reducing the moment of inertia. The moment of inertia about the axis of a round component is I=(Π/4)(radius)4. Similarly, the moment of inertia about the axis of a round tubular component (e.g., tubular member 20) is I=(Π/4)(ROD4−RID4), where ROD is the radius of the outer dimension of the tube and RID is the radius of the inner dimension of the tube. Thus, as the radius of tubular member 20 varies, the moment of inertia changes by the fourth power of the radius. Based on this relationship, the outer diameter OD and/or the inner diameter ID can be selected so as to provide tubular member with the desired flexibility characteristics. Moreover, by altering the moment of inertia to the desired extent, tubular member 20 can be fabricated with a “custom” or specially-tailored flexibility characteristics.
Thinning tube wall 44 may be accomplished in a number of different manners. The appropriate manner for thinning tube wall 44 may depend on the material utilized for tubular member. For example, embodiments of tubular member 20 that are made from a polymer may be molded, cast, extruded, or otherwise formed into the desired shape. In embodiments where a metal is utilized, some of these or similar methods may be used. Additionally, other techniques may also be utilized including, for example, grinding (e.g., centerless grinding, end-grinding, plunge grinding, OD grinding, etc.), chemical etching, metal forming, or the like may also be utilized.
Fabricating a tubular member that is appropriately sized for use in guidewire 10 and has the appropriately thinned tube wall 44 may prove challenging, particularly when tubular member 20 is made from a shape-memory and/or super-elastic material (e.g., shape-memory and/or super-elastic nickel-titanium alloy) where the desirable shape-memory and/or super-elastic properties may be altered by using shaping techniques such as molding, casting, etc. Because of this, it may be necessary in some instances to utilize a more mechanical technique to thin tube wall 44. Additionally, thinning tube wall 44 along the exterior of tubular member 20 may be accomplished used relatively convention grinding (e.g., conventional centerless grinding) techniques. However, conventional grinding may not be suitable for thinning tube wall 44 along the interior of tubular member 20. Therefore, it may be necessary to formulate an alternative method for thinning tube wall 44 along the interior of tubular member 20. In some embodiments, tube wall 44 can be thinned by fabricating a tool having an exterior corresponding to the desired final shape for tubular member 20 along it interior and then using the tool to bore out or otherwise shape tubular member 20 in the desired manner. Other suitable techniques may also be utilized without departing from the spirit of the invention.
As indicated above, thinning tube wall 44 may desirable impact the flexibility characteristics of tubular member 20. Because of this, the thinned portions of tube wall 44 may be disposed at a desired location including, for example, the distal tip of guidewire 10, adjacent a transition in materials and/or components, or at any other suitable location.
The embodiments illustrated in
The materials that can be used for the various components of guidewire 10 (and/or other guidewires disclosed herein) may include those commonly associated with medical devices. For simplicity purposes, the following discussion makes reference to tubular member 20 and other components of guidewire 10. However, this is not intended to limit the invention as the discussion may be applied to other similar tubular members and/or components of tubular members or devices disclosed herein.
Core wire 18, and/or tubular member 20, and/or connector 26, and/or tip member 28, and the like may be made from a metal, metal alloy, polymer (some examples of which are disclosed below), a metal-polymer composite, combinations thereof, and the like, or any other suitable material. Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: N06625 such as INCONEL® 625, UNS: N06022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: N04400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; titanium; combinations thereof; and the like; or any other suitable material.
As alluded to above, within the family of commercially available nickel-titanium or nitinol alloys, is a category designated “linear elastic” or “non-super-elastic” which, although may be similar in chemistry to conventional shape memory and super elastic varieties, may exhibit distinct and useful mechanical properties. Linear elastic and/or non-super-elastic nitinol may be distinguished from super elastic nitinol in that the linear elastic and/or non-super-elastic nitinol does not display a substantial “superelastic plateau” or “flag region” in its stress/strain curve like super elastic nitinol does. Instead, in the linear elastic and/or non-super-elastic nitinol, as recoverable strain increases, the stress continues to increase in a substantially linear, or a somewhat, but not necessarily entirely linear relationship until plastic deformation begins or at least in a relationship that is more linear that the super elastic plateau and/or flag region that may be seen with super elastic nitinol. Thus, for the purposes of this disclosure linear elastic and/or non-super-elastic nitinol may also be termed “substantially” linear elastic and/or non-super-elastic nitinol.
In some cases, linear elastic and/or non-super-elastic nitinol may also be distinguishable from super elastic nitinol in that linear elastic and/or non-super-elastic nitinol may accept up to about 2-5% strain while remaining substantially elastic (e.g., before plastically deforming) whereas super elastic nitinol may accept up to about 8% strain before plastically deforming. Both of these materials can be distinguished from other linear elastic materials such as stainless steel (that can also can be distinguished based on its composition), which may accept only about 0.2-0.44% strain before plastically deforming.
In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy is an alloy that does not show any martensite/austenite phase changes that are detectable by DSC and DMTA analysis over a large temperature range. For example, in some embodiments, there may be no martensite/austenite phase changes detectable by DSC and DMTA analysis in the range of about −60° C. to about 120° C. in the linear elastic and/or non-super-elastic nickel-titanium alloy. The mechanical bending properties of such material may therefore be generally inert to the effect of temperature over this very broad range of temperature. In some embodiments, the mechanical bending properties of the linear elastic and/or non-super-elastic nickel-titanium alloy at ambient or room temperature are substantially the same as the mechanical properties at body temperature, for example, in that they do not display a super-elastic plateau and/or flag region. In other words, across a broad temperature range, the linear elastic and/or non-super-elastic nickel-titanium alloy maintains its linear elastic and/or non-super-elastic characteristics and/or properties and has essentially no yield point.
In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy may be in the range of about 50 to about 60 weight percent nickel, with the remainder being essentially titanium. In some embodiments, the composition is in the range of about 54 to about 57 weight percent nickel. One example of a suitable nickel-titanium alloy is FHP-NT alloy commercially available from Furukawa Techno Material Co. of Kanagawa, Japan. Some examples of nickel titanium alloys are disclosed in U.S. Pat. Nos. 5,238,004 and 6,508,803, which are incorporated herein by reference. Other suitable materials may include ULTANIUM™ (available from Neo-Metrics) and GUM METAL™ (available from Toyota). In some other embodiments, a superelastic alloy, for example a superelastic nitinol can be used to achieve desired properties.
In at least some embodiments, portions or all of core wire 18 and/or tubular member 20 may also be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of guidewire 10 in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like. Additionally, other radiopaque marker bands and/or coils may also be incorporated into the design of guidewire 10 to achieve the same result.
In some embodiments, a degree of MRI compatibility is imparted into guidewire 10. For example, to enhance compatibility with Magnetic Resonance Imaging (MRI) machines, it may be desirable to make core wire 18 and/or tubular member 20, or other portions of the guidewire 10, in a manner that would impart a degree of MRI compatibility. For example, core wire 18 and/or tubular member 20, or portions thereof, may be made of a material that does not substantially distort the image and create substantial artifacts (artifacts are gaps in the image). Certain ferromagnetic materials, for example, may not be suitable because they may create artifacts in an MRI image. Core wire 18 and/or tubular member 20, or portions thereof, may also be made from a material that the MRI machine can image. Some materials that exhibit these characteristics include, for example, tungsten, cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nitinol, and the like, and others.
Referring now to core wire 18, the entire core wire 18 can be made of the same material along its length, or in some embodiments, can include portions or sections made of different materials. In some embodiments, the material used to construct core wire 18 is chosen to impart varying flexibility and stiffness characteristics to different portions of core wire 18. For example, proximal section 22 and distal section 24 of core wire 18 may be formed of different materials, for example materials having different moduli of elasticity, resulting in a difference in flexibility. In some embodiments, the material used to construct proximal section 22 can be relatively stiff for pushability and torqueability, and the material used to construct distal section 24 can be relatively flexible by comparison for better lateral trackability and steerability. For example, proximal section 22 can be formed of straightened 304v stainless steel wire or ribbon and distal section 24 can be formed of a straightened super elastic or linear elastic alloy, for example a nickel-titanium alloy wire or ribbon.
In embodiments where different portions of core wire 18 are made of different materials, the different portions can be connected using any suitable connecting techniques and/or with connector 26. For example, the different portions of core wire 18 can be connected using welding (including laser welding), soldering, brazing, adhesive, or the like, or combinations thereof. These techniques can be utilized regardless of whether or not connector 26 is utilized. Connector 26 may include any structure generally suitable for connecting portions of a guidewire. One example of a suitable structure includes a structure such as a hypotube or a coiled wire which has an inside diameter sized appropriately to receive and connect to the ends of the proximal portion and the distal portion. Essentially any suitable configuration and/or structure can be utilized for connector 26 including those connectors described in U.S. Pat. Nos. 6,918,882 and 7,071,197 and/or in U.S. Patent Pub. No. 2006-0122537, the entire disclosures of which are herein incorporated by reference.
A sheath or covering (not shown) may be disposed over portions or all of core wire 18 and/or tubular member 20 that may define a generally smooth outer surface for guidewire 10. In other embodiments, however, such a sheath or covering may be absent from a portion of all of guidewire 10, such that tubular member 20 and/or core wire 18 may form the outer surface. The sheath may be made from a polymer or any other suitable material. Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane (for example, Polyurethane 85A), polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly praraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), poly(styrene-b-isobutylene-b-styrene) (for example, SIBS and/or SIBS 50A), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments the sheath can be blended with a liquid crystal polymer (LCP). For example, the mixture can contain up to about 6% LCP.
In some embodiments, the exterior surface of the guidewire 10 (including, for example, the exterior surface of core wire 18 and/or the exterior surface of tubular member 20) may be sandblasted, beadblasted, sodium bicarbonate-blasted, electropolished, etc. In these as well as in some other embodiments, a coating, for example a lubricious, a hydrophilic, a protective, or other type of coating may be applied over portions or all of the sheath, or in embodiments without a sheath over portion of core wire 18 and/or tubular member, or other portions of device 10. Alternatively, the sheath may comprise a lubricious, hydrophilic, protective, or other type of coating. Hydrophobic coatings such as fluoropolymers provide a dry lubricity which improves guidewire handling and device exchanges. Lubricious coatings improve steerability and improve lesion crossing capability. Suitable lubricious polymers are well known in the art and may include silicone and the like, polymers such as high-density polyethylene (HDPE), polytetrafluoroethylene (PTFE), polyarylene oxides, polyvinylpyrrolidones, polyvinylalcohols, hydroxy alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof. Hydrophilic polymers may be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coatings with suitable lubricity, bonding, and solubility. Some other examples of such coatings and materials and methods used to create such coatings can be found in U.S. Pat. Nos. 6,139,510 and 5,772,609, the entire disclosures of which are incorporated herein by reference.
The coating and/or sheath may be formed, for example, by coating, extrusion, co-extrusion, interrupted layer co-extrusion (ILC), or fusing several segments end-to-end. The same may be true of tip member 28. The layer may have a uniform stiffness or a gradual reduction in stiffness from the proximal end to the distal end thereof. The gradual reduction in stiffness may be continuous as by ILC or may be stepped as by fusing together separate extruded tubular segments. The outer layer may be impregnated with a radiopaque filler material to facilitate radiographic visualization. Those skilled in the art will recognize that these materials can vary widely without deviating from the scope of the present invention.
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
Number | Name | Date | Kind |
---|---|---|---|
1553227 | Feyk et al. | Sep 1925 | A |
1866888 | Hawley | Jul 1932 | A |
2275827 | Plensler | Mar 1942 | A |
2413805 | Vickers | Jan 1947 | A |
2441166 | Raspert | May 1948 | A |
2561890 | Stoddard | Jul 1951 | A |
2722614 | Fryklund | Nov 1955 | A |
2857536 | Light | Oct 1958 | A |
2864017 | Waltscheff | Dec 1958 | A |
2871793 | Michie et al. | Feb 1959 | A |
3249776 | Anderson et al. | May 1966 | A |
3322984 | Anderson | May 1967 | A |
3334253 | Hill | Aug 1967 | A |
3363470 | Yavne | Jan 1968 | A |
3452227 | Welch | Jun 1969 | A |
3452742 | Muller | Jul 1969 | A |
3463953 | Maxwell | Aug 1969 | A |
3512019 | Durand | May 1970 | A |
3544868 | Bates | Dec 1970 | A |
3625200 | Muller | Dec 1971 | A |
3686990 | Margolien | Aug 1972 | A |
3841308 | Tate | Oct 1974 | A |
3890977 | Wilson | Jun 1975 | A |
3906938 | Fleischhacker | Sep 1975 | A |
4000672 | Sitterer et al. | Jan 1977 | A |
4003369 | Heilman et al. | Jan 1977 | A |
4020829 | Willson et al. | May 1977 | A |
4142119 | Madey | Feb 1979 | A |
4215703 | Wilson | Aug 1980 | A |
4330725 | Hintz | May 1982 | A |
4425919 | Alston, Jr. et al. | Jan 1984 | A |
4476754 | Ducret | Oct 1984 | A |
4482828 | Vergues et al. | Nov 1984 | A |
4545390 | Leary | Oct 1985 | A |
4563181 | Wijayarathna et al. | Jan 1986 | A |
4574670 | Johnson | Mar 1986 | A |
4580551 | Siegmund et al. | Apr 1986 | A |
4583404 | Bernard et al. | Apr 1986 | A |
4635270 | Gürs | Jan 1987 | A |
4665906 | Jervis | May 1987 | A |
4676249 | Arenas et al. | Jun 1987 | A |
4721117 | Mar et al. | Jan 1988 | A |
4737153 | Shimamura et al. | Apr 1988 | A |
4763647 | Gambale | Aug 1988 | A |
4774949 | Fogarty | Oct 1988 | A |
4781092 | Gaiser | Nov 1988 | A |
4781186 | Simpson et al. | Nov 1988 | A |
4786220 | Fildes et al. | Nov 1988 | A |
4790331 | Okada et al. | Dec 1988 | A |
4800890 | Cramer | Jan 1989 | A |
4811743 | Stevens | Mar 1989 | A |
4827941 | Taylor et al. | May 1989 | A |
4831858 | Yoshizawa | May 1989 | A |
4832047 | Sepetka et al. | May 1989 | A |
4846186 | Box et al. | Jul 1989 | A |
4846193 | Tremulis et al. | Jul 1989 | A |
4867173 | Leoni | Sep 1989 | A |
4875489 | Messner et al. | Oct 1989 | A |
4884579 | Engelson | Dec 1989 | A |
4911148 | Sosnowski et al. | Mar 1990 | A |
4917102 | Miller et al. | Apr 1990 | A |
4922164 | Jacobsen et al. | May 1990 | A |
4922777 | Kawabata | May 1990 | A |
4932959 | Horzewski et al. | Jun 1990 | A |
4934380 | Toledo | Jun 1990 | A |
4953553 | Tremulis | Sep 1990 | A |
4954022 | Underwood et al. | Sep 1990 | A |
4955384 | Taylor et al. | Sep 1990 | A |
4955862 | Sepetka | Sep 1990 | A |
4960410 | Pinchuk | Oct 1990 | A |
4964409 | Tremulis | Oct 1990 | A |
4966163 | Kraus et al. | Oct 1990 | A |
4968306 | Huss et al. | Nov 1990 | A |
4973321 | Michelson | Nov 1990 | A |
4985022 | Fearnot et al. | Jan 1991 | A |
4989608 | Ratner | Feb 1991 | A |
4990143 | Sheridan | Feb 1991 | A |
4994069 | Ritchart et al. | Feb 1991 | A |
4998923 | Samson et al. | Mar 1991 | A |
5007434 | Doyle et al. | Apr 1991 | A |
5009137 | Dannatt | Apr 1991 | A |
5040543 | Badera et al. | Aug 1991 | A |
5050606 | Tremulis | Sep 1991 | A |
5052404 | Hodgson | Oct 1991 | A |
5059177 | Alcebo et al. | Oct 1991 | A |
5063935 | Gamble | Nov 1991 | A |
5065769 | De Toledo | Nov 1991 | A |
5095915 | Engelson | Mar 1992 | A |
5106455 | Jacobsen et al. | Apr 1992 | A |
5109830 | Cho | May 1992 | A |
5125395 | Adair | Jun 1992 | A |
5135531 | Shiber | Aug 1992 | A |
5144959 | Gambale et al. | Sep 1992 | A |
5147317 | Shank et al. | Sep 1992 | A |
5181668 | Tsuji et al. | Jan 1993 | A |
5205830 | Dassa et al. | Apr 1993 | A |
5211183 | Wilson | May 1993 | A |
5228441 | Lundquist | Jul 1993 | A |
5238004 | Sahatjian et al. | Aug 1993 | A |
5242759 | Hall | Sep 1993 | A |
5243996 | Hall | Sep 1993 | A |
5250069 | Nobuyoshi et al. | Oct 1993 | A |
5254106 | Feaster | Oct 1993 | A |
5254107 | Soltesz | Oct 1993 | A |
5256144 | Kraus et al. | Oct 1993 | A |
5257974 | Cox | Nov 1993 | A |
5259393 | Corso, Jr. et al. | Nov 1993 | A |
5267979 | Appling et al. | Dec 1993 | A |
5267982 | Sylvanowicz | Dec 1993 | A |
5279562 | Sirhan et al. | Jan 1994 | A |
5284128 | Hart | Feb 1994 | A |
5300032 | Hibbs et al. | Apr 1994 | A |
5304131 | Paskar | Apr 1994 | A |
5306252 | Yutori et al. | Apr 1994 | A |
5308435 | Ruggles et al. | May 1994 | A |
5315906 | Ferenczi et al. | May 1994 | A |
5315996 | Lundquist | May 1994 | A |
5318529 | Kontos | Jun 1994 | A |
5322064 | Lundquist | Jun 1994 | A |
5329923 | Lundquist | Jul 1994 | A |
5333620 | Moutafis et al. | Aug 1994 | A |
5334145 | Lundquist et al. | Aug 1994 | A |
5336205 | Zenzen et al. | Aug 1994 | A |
5341818 | Abrams et al. | Aug 1994 | A |
5345937 | Middleman et al. | Sep 1994 | A |
5345945 | Hodgson et al. | Sep 1994 | A |
5354623 | Hall | Oct 1994 | A |
5358493 | Schweich et al. | Oct 1994 | A |
5358796 | Nakamura et al. | Oct 1994 | A |
5365942 | Shank | Nov 1994 | A |
5365943 | Jansen | Nov 1994 | A |
5368564 | Savage | Nov 1994 | A |
5368661 | Nakamura et al. | Nov 1994 | A |
5376084 | Bacich et al. | Dec 1994 | A |
5381782 | DeLaRama et al. | Jan 1995 | A |
5406960 | Corso, Jr. | Apr 1995 | A |
5411476 | Abrams | May 1995 | A |
5425723 | Wang | Jun 1995 | A |
5437288 | Schwartz et al. | Aug 1995 | A |
5438993 | Lynch et al. | Aug 1995 | A |
5439000 | Gunderson et al. | Aug 1995 | A |
5441483 | Avitall | Aug 1995 | A |
5441489 | Utsumi et al. | Aug 1995 | A |
5447812 | Fukuda et al. | Sep 1995 | A |
5454787 | Lundquist | Oct 1995 | A |
5460187 | Daigle et al. | Oct 1995 | A |
5470330 | Goldenberg et al. | Nov 1995 | A |
5476701 | Berger | Dec 1995 | A |
5477856 | Lundquist | Dec 1995 | A |
5496294 | Hergenrother et al. | Mar 1996 | A |
5497785 | Viera | Mar 1996 | A |
5507301 | Wasicek et al. | Apr 1996 | A |
5507729 | Lindenberg et al. | Apr 1996 | A |
5507751 | Goode et al. | Apr 1996 | A |
5507766 | Kugo et al. | Apr 1996 | A |
5514128 | Hillsman et al. | May 1996 | A |
5520194 | Miyata et al. | May 1996 | A |
5520645 | Imran et al. | May 1996 | A |
5531719 | Takahashi | Jul 1996 | A |
5533985 | Wang | Jul 1996 | A |
5546958 | Thorud et al. | Aug 1996 | A |
5551444 | Finlayson | Sep 1996 | A |
5554139 | Okajima | Sep 1996 | A |
5562619 | Mirarchi et al. | Oct 1996 | A |
5569197 | Helmus et al. | Oct 1996 | A |
5569200 | Umeno et al. | Oct 1996 | A |
5569218 | Berg | Oct 1996 | A |
5571073 | Castillo | Nov 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5584821 | Hobbs et al. | Dec 1996 | A |
5599326 | Carter | Feb 1997 | A |
5599492 | Engelson | Feb 1997 | A |
5601539 | Corso, Jr. | Feb 1997 | A |
5605162 | Mirzaee et al. | Feb 1997 | A |
5622184 | Ashby et al. | Apr 1997 | A |
5630806 | Inagaki et al. | May 1997 | A |
5637089 | Abrams et al. | Jun 1997 | A |
5656011 | Uihlein et al. | Aug 1997 | A |
5658264 | Samson et al. | Aug 1997 | A |
5666968 | Imran et al. | Sep 1997 | A |
5666969 | Urick et al. | Sep 1997 | A |
5669926 | Aust et al. | Sep 1997 | A |
5676659 | McGurk | Oct 1997 | A |
5676697 | McDonald | Oct 1997 | A |
5682894 | Orr et al. | Nov 1997 | A |
5690120 | Jacobsen et al. | Nov 1997 | A |
5720300 | Fagan et al. | Feb 1998 | A |
5722609 | Murakami | Mar 1998 | A |
5728063 | Preissman et al. | Mar 1998 | A |
5741429 | Donadio, III et al. | Apr 1998 | A |
5746701 | Noone | May 1998 | A |
5769830 | Parker | Jun 1998 | A |
5772609 | Nguyen et al. | Jun 1998 | A |
5782809 | Umeno et al. | Jul 1998 | A |
5788653 | Lorenzo | Aug 1998 | A |
5788654 | Schwager | Aug 1998 | A |
5788707 | Del Toro et al. | Aug 1998 | A |
5792124 | Horrigan et al. | Aug 1998 | A |
5797856 | Frisbie et al. | Aug 1998 | A |
5800454 | Jacobsen et al. | Sep 1998 | A |
5807075 | Jacobsen et al. | Sep 1998 | A |
5807249 | Qin et al. | Sep 1998 | A |
5810885 | Zinger | Sep 1998 | A |
5813996 | St. Germain et al. | Sep 1998 | A |
5827225 | Ma Schwab | Oct 1998 | A |
5827242 | Follmer et al. | Oct 1998 | A |
5833632 | Jacobsen et al. | Nov 1998 | A |
5833672 | Kawata et al. | Nov 1998 | A |
5836926 | Peterson et al. | Nov 1998 | A |
5843050 | Jones et al. | Dec 1998 | A |
5843244 | Pelton et al. | Dec 1998 | A |
5851203 | van Muiden | Dec 1998 | A |
5895378 | Nita | Apr 1999 | A |
5897537 | Berg et al. | Apr 1999 | A |
5902254 | Magram | May 1999 | A |
5902290 | Peacock, III et al. | May 1999 | A |
5902499 | Richerzhagen | May 1999 | A |
5904657 | Unsworth et al. | May 1999 | A |
5906618 | Larson, III | May 1999 | A |
5911715 | Berg et al. | Jun 1999 | A |
5911717 | Jacobsen et al. | Jun 1999 | A |
5916177 | Schwager | Jun 1999 | A |
5916178 | Noone | Jun 1999 | A |
5916194 | Jacobsen et al. | Jun 1999 | A |
5931830 | Jacobsen et al. | Aug 1999 | A |
5935108 | Katoh et al. | Aug 1999 | A |
5947940 | Beisel | Sep 1999 | A |
5951539 | Nita et al. | Sep 1999 | A |
5971975 | Mills et al. | Oct 1999 | A |
5980471 | Jafari | Nov 1999 | A |
6001068 | Uchino et al. | Dec 1999 | A |
6004279 | Crowley et al. | Dec 1999 | A |
6007478 | Siess et al. | Dec 1999 | A |
6014919 | Jacobsen et al. | Jan 2000 | A |
6017319 | Jacobsen et al. | Jan 2000 | A |
6022341 | Lentz | Feb 2000 | A |
6022343 | Johnson et al. | Feb 2000 | A |
6022369 | Jacobsen et al. | Feb 2000 | A |
6024730 | Pagan | Feb 2000 | A |
6027461 | Walker et al. | Feb 2000 | A |
6042553 | Solar et al. | Mar 2000 | A |
6045547 | Ren et al. | Apr 2000 | A |
6048339 | Zirps et al. | Apr 2000 | A |
6056702 | Lorenzo | May 2000 | A |
6063101 | Jacobsen et al. | May 2000 | A |
6063200 | Jacobsen et al. | May 2000 | A |
6066361 | Jacobsen et al. | May 2000 | A |
6090099 | Samson et al. | Jul 2000 | A |
6106485 | McMahon | Aug 2000 | A |
6106488 | Fleming et al. | Aug 2000 | A |
6135992 | Wang | Oct 2000 | A |
6139510 | Palermo | Oct 2000 | A |
6165292 | Abrams et al. | Dec 2000 | A |
6171296 | Chow | Jan 2001 | B1 |
6183410 | Jacobsen et al. | Feb 2001 | B1 |
6193686 | Estrada et al. | Feb 2001 | B1 |
6197014 | Samson et al. | Mar 2001 | B1 |
6203485 | Urick | Mar 2001 | B1 |
RE37148 | Shank | Apr 2001 | E |
6214042 | Jacobsen et al. | Apr 2001 | B1 |
6228073 | Noone et al. | May 2001 | B1 |
6248082 | Jafari | Jun 2001 | B1 |
6251092 | Qin et al. | Jun 2001 | B1 |
6254549 | Ramzipoor | Jul 2001 | B1 |
6260458 | Jacobsen et al. | Jul 2001 | B1 |
6273404 | Holman et al. | Aug 2001 | B1 |
6273876 | Klima et al. | Aug 2001 | B1 |
6273879 | Keith et al. | Aug 2001 | B1 |
6290656 | Boyle et al. | Sep 2001 | B1 |
6296616 | McMahon | Oct 2001 | B1 |
6296631 | Chow | Oct 2001 | B2 |
6302870 | Jacobsen et al. | Oct 2001 | B1 |
6325790 | Trotta | Dec 2001 | B1 |
6338725 | Hermann et al. | Jan 2002 | B1 |
6346091 | Jacobsen et al. | Feb 2002 | B1 |
6352515 | Anderson et al. | Mar 2002 | B1 |
6355005 | Powell et al. | Mar 2002 | B1 |
6355027 | Le et al. | Mar 2002 | B1 |
6368315 | Gillis et al. | Apr 2002 | B1 |
6368316 | Jansen et al. | Apr 2002 | B1 |
6375628 | Zadno-Azizi et al. | Apr 2002 | B1 |
6375774 | Lunn et al. | Apr 2002 | B1 |
6379369 | Abrams et al. | Apr 2002 | B1 |
6390993 | Cornish et al. | May 2002 | B1 |
6398758 | Jacobsen et al. | Jun 2002 | B1 |
6428489 | Jacobsen et al. | Aug 2002 | B1 |
6428512 | Anderson et al. | Aug 2002 | B1 |
6431039 | Jacobsen et al. | Aug 2002 | B1 |
6440088 | Jacobsen | Aug 2002 | B1 |
6478778 | Jacobsen et al. | Nov 2002 | B1 |
6488637 | Eder et al. | Dec 2002 | B1 |
6491648 | Cornish et al. | Dec 2002 | B1 |
6491671 | Larson, III et al. | Dec 2002 | B1 |
6503244 | Hayman | Jan 2003 | B2 |
6508803 | Horikawa et al. | Jan 2003 | B1 |
6524301 | Wilson et al. | Feb 2003 | B1 |
6530934 | Jacobsen et al. | Mar 2003 | B1 |
6547779 | Levine et al. | Apr 2003 | B2 |
6553880 | Jacobsen et al. | Apr 2003 | B2 |
6556873 | Smits | Apr 2003 | B1 |
6562021 | Derbin et al. | May 2003 | B1 |
6579246 | Jacobsen et al. | Jun 2003 | B2 |
6602207 | Mam et al. | Aug 2003 | B1 |
6602280 | Chobotov | Aug 2003 | B2 |
6610046 | Usami et al. | Aug 2003 | B1 |
6623448 | Slater | Sep 2003 | B2 |
6636758 | Sanchez et al. | Oct 2003 | B2 |
6638266 | Wilson et al. | Oct 2003 | B2 |
6648024 | Wang | Nov 2003 | B2 |
6652508 | Griffin et al. | Nov 2003 | B2 |
6663614 | Carter | Dec 2003 | B1 |
6682493 | Mirigian | Jan 2004 | B2 |
6689120 | Gerdts | Feb 2004 | B1 |
6702762 | Jafari et al. | Mar 2004 | B2 |
6702802 | Hancock et al. | Mar 2004 | B1 |
6712826 | Lui | Mar 2004 | B2 |
6730095 | Olson, Jr. et al. | May 2004 | B2 |
6749560 | Konstorum et al. | Jun 2004 | B1 |
6766720 | Jacobsen et al. | Jul 2004 | B1 |
6777644 | Peacock, III et al. | Aug 2004 | B2 |
6811544 | Schaer | Nov 2004 | B2 |
6837898 | Boyle et al. | Jan 2005 | B2 |
6866642 | Kellerman et al. | Mar 2005 | B2 |
6887235 | O'Connor et al. | May 2005 | B2 |
6918882 | Skujins et al. | Jul 2005 | B2 |
6939593 | Wang | Sep 2005 | B2 |
6953470 | Holman et al. | Oct 2005 | B2 |
6997937 | Jacobsen et al. | Feb 2006 | B2 |
7001369 | Griffin et al. | Feb 2006 | B2 |
7071197 | Leonardi et al. | Jul 2006 | B2 |
7074197 | Reynolds et al. | Jul 2006 | B2 |
7153277 | Skujins et al. | Dec 2006 | B2 |
7153320 | Euteneuer et al. | Dec 2006 | B2 |
7166099 | Devens, Jr. | Jan 2007 | B2 |
7169118 | Reynolds et al. | Jan 2007 | B2 |
7182735 | Shireman et al. | Feb 2007 | B2 |
RE39668 | Bagaoisan et al. | May 2007 | E |
20020013540 | Jacobsen et al. | Jan 2002 | A1 |
20020019599 | Rooney et al. | Feb 2002 | A1 |
20030009208 | Snyder et al. | Jan 2003 | A1 |
20030060732 | Jacobsen et al. | Mar 2003 | A1 |
20030069522 | Jacobsen et al. | Apr 2003 | A1 |
20030216668 | Howland et al. | Nov 2003 | A1 |
20040030266 | Murayama et al. | Feb 2004 | A1 |
20040116831 | Vrba | Jun 2004 | A1 |
20040142643 | Miller et al. | Jul 2004 | A1 |
20040167436 | Reynolds et al. | Aug 2004 | A1 |
20040167437 | Sharrow et al. | Aug 2004 | A1 |
20040167441 | Reynolds et al. | Aug 2004 | A1 |
20040181174 | Davis et al. | Sep 2004 | A2 |
20040181176 | Jafari et al. | Sep 2004 | A1 |
20050004523 | Osborne et al. | Jan 2005 | A1 |
20050027212 | Segner et al. | Feb 2005 | A1 |
20050115624 | Walak | Jun 2005 | A1 |
20060027009 | Martin et al. | Feb 2006 | A1 |
20060121218 | Obara et al. | Jun 2006 | A1 |
20060122537 | Reynolds et al. | Jun 2006 | A1 |
20060189896 | Davis et al. | Aug 2006 | A1 |
20060264904 | Kerby et al. | Nov 2006 | A1 |
20070049846 | Bown et al. | Mar 2007 | A1 |
20070100285 | Griffin et al. | May 2007 | A1 |
20070100424 | Chew et al. | May 2007 | A1 |
20070232957 | Murayama et al. | Oct 2007 | A1 |
20080021347 | Jacobsen et al. | Jan 2008 | A1 |
20080021348 | Jacobsen et al. | Jan 2008 | A1 |
20080021400 | Jacobsen et al. | Jan 2008 | A1 |
20080021401 | Jacobsen et al. | Jan 2008 | A1 |
20080021402 | Jacobsen et al. | Jan 2008 | A1 |
20080021403 | Jacobsen et al. | Jan 2008 | A1 |
20080021404 | Jacobsen et al. | Jan 2008 | A1 |
20080021405 | Jacobsen et al. | Jan 2008 | A1 |
20080021406 | Jacobsen et al. | Jan 2008 | A1 |
20080021407 | Jacobsen et al. | Jan 2008 | A1 |
20080021408 | Jacobsen et al. | Jan 2008 | A1 |
20080077119 | Snyder et al. | Mar 2008 | A1 |
20080200839 | Bunch et al. | Aug 2008 | A1 |
20090043283 | Turnlund et al. | Feb 2009 | A1 |
Number | Date | Country |
---|---|---|
723040 | Dec 1997 | AU |
733966 | Apr 1998 | AU |
PI 9712829 | Jan 2000 | BR |
2266685 | May 2006 | CA |
2255781 | Mar 2007 | CA |
1230914 | Oct 1999 | CN |
285514 | Dec 1990 | DE |
0 045 931 | Feb 1982 | EP |
0 069 522 | Jan 1983 | EP |
0 087 933 | Sep 1983 | EP |
0 111 044 | Jun 1984 | EP |
0 181 174 | May 1986 | EP |
0 215 173 | Mar 1987 | EP |
0317905 | May 1989 | EP |
0 377 453 | Jul 1990 | EP |
0 565 065 | Jun 1996 | EP |
0 778 039 | Jun 1997 | EP |
0 778 040 | Jun 1997 | EP |
0 865 772 | Sep 1998 | EP |
0 865 773 | Sep 1998 | EP |
0 521 595 | May 1999 | EP |
0 917 885 | Aug 1999 | EP |
0 790 066 | Apr 2000 | EP |
0 812 599 | Aug 2002 | EP |
0 608 853 | Apr 2003 | EP |
0 935 947 | Dec 2004 | EP |
0 937 481 | Apr 2005 | EP |
0 934 141 | Nov 2005 | EP |
0 778 038 | Jun 2006 | EP |
2130885 | Jun 1984 | GB |
2214354 | Aug 1989 | GB |
2257269 | Jan 1993 | GB |
58-8522 | Jan 1983 | JP |
60-091858 | May 1985 | JP |
61-022752 | Jan 1986 | JP |
62-023361 | Jan 1987 | JP |
62-089470 | Apr 1987 | JP |
62-299277 | Dec 1987 | JP |
63-93516 | Apr 1988 | JP |
63-181774 | Jul 1988 | JP |
63-217966 | Sep 1988 | JP |
10-89956 | Apr 1989 | JP |
1-135363 | May 1989 | JP |
1-158936 | Jun 1989 | JP |
2-107268 | Apr 1990 | JP |
03-122850 | Dec 1991 | JP |
4-061840 | Feb 1992 | JP |
4-099963 | Mar 1992 | JP |
4-213069 | Aug 1992 | JP |
4-213070 | Aug 1992 | JP |
4-236965 | Aug 1992 | JP |
5-149969 | Jun 1993 | JP |
5-506806 | Oct 1993 | JP |
5-309519 | Nov 1993 | JP |
5-507857 | Nov 1993 | JP |
6-501179 | Feb 1994 | JP |
6-31749 | Apr 1994 | JP |
6-169996 | Jun 1994 | JP |
6-63224 | Sep 1994 | JP |
6-312313 | Nov 1994 | JP |
7-28562 | May 1995 | JP |
7-124164 | May 1995 | JP |
7-124263 | May 1995 | JP |
7-136280 | May 1995 | JP |
7-148264 | Jun 1995 | JP |
7-505561 | Jun 1995 | JP |
7-37199 | Jul 1995 | JP |
7-185009 | Jul 1995 | JP |
7-255855 | Oct 1995 | JP |
7-275366 | Oct 1995 | JP |
7-51067 | Nov 1995 | JP |
8-229888 | Sep 1996 | JP |
8-509141 | Oct 1996 | JP |
8-317988 | Dec 1996 | JP |
9-000164 | Apr 1997 | JP |
9-276413 | Oct 1997 | JP |
9-294813 | Nov 1997 | JP |
10-118193 | May 1998 | JP |
10-328191 | Dec 1998 | JP |
11-267224 | Oct 1999 | JP |
2000-197704 | Jul 2000 | JP |
2000-510722 | Aug 2000 | JP |
2000-511083 | Aug 2000 | JP |
3081831 | Aug 2000 | JP |
2001-500808 | Jan 2001 | JP |
2002-529137 | Sep 2002 | JP |
3325828 | Sep 2002 | JP |
2002-542901 | Dec 2002 | JP |
2002-543896 | Dec 2002 | JP |
2003-517893 | Jun 2003 | JP |
3649604 | May 2005 | JP |
2005-534407 | Nov 2005 | JP |
712908 | Jan 1980 | SU |
758421 | Aug 1980 | SU |
1529365 | Dec 1989 | SU |
WO 9002520 | Mar 1990 | WO |
WO 9113364 | Sep 1991 | WO |
WO 9204072 | Mar 1992 | WO |
WO 9207619 | May 1992 | WO |
WO 9304722 | Mar 1993 | WO |
WO 9311313 | Jun 1993 | WO |
WO 9524236 | Sep 1995 | WO |
WO 9532834 | Dec 1995 | WO |
WO 9619255 | Jun 1996 | WO |
WO 9638193 | Dec 1996 | WO |
WO 9710022 | Mar 1997 | WO |
WO 9725914 | Jul 1997 | WO |
WO 9743949 | Nov 1997 | WO |
WO 9744083 | Nov 1997 | WO |
WO 9744086 | Nov 1997 | WO |
WO 9810694 | Mar 1998 | WO |
WO 9904847 | Feb 1999 | WO |
WO 9911313 | Mar 1999 | WO |
WO 0027303 | May 2000 | WO |
WO 0030710 | Jun 2000 | WO |
WO 0048645 | Aug 2000 | WO |
WO 0057943 | Oct 2000 | WO |
WO 0066199 | Nov 2000 | WO |
WO 0067845 | Nov 2000 | WO |
WO 0072907 | Dec 2000 | WO |
WO 0128620 | Apr 2001 | WO |
WO 0136034 | May 2001 | WO |
WO 0145773 | Jun 2001 | WO |
WO 0145912 | Jun 2001 | WO |
WO 0193920 | Dec 2001 | WO |
WO 0213682 | Feb 2002 | WO |
WO 02062540 | Aug 2002 | WO |
WO 03004086 | Jan 2003 | WO |
WO 03008148 | Jan 2003 | WO |
WO 03041783 | May 2003 | WO |
WO 2004012804 | Feb 2004 | WO |
WO 2004047899 | Jun 2004 | WO |
WO 2007050718 | May 2007 | WO |
WO 2008034010 | Mar 2008 | WO |
Entry |
---|
“Mechanical Design and Systems Handbook”, H.A. Rothbart, 1964, p. 33-13 (one sheet). |
Number | Date | Country | |
---|---|---|---|
20100063480 A1 | Mar 2010 | US |